MSN Laboratories Private Limited Febuxostat Export Data — India (DGFT 2022–2026)

Name: MSN Laboratories Private Limited Febuxostat Export Records India — #2 Exporter, 342 Shipments, $6.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Febuxostat

India Pharmaceutical Trade Intelligence

$48.9M182 Suppliers91 CountriesHS 30049099

ExportsIndia → PHILIPPINES52.3%India → UNITED STATES23.7%

ImportsCHINA → India$10.6K UNITED STATES → India$5.5K

#1 Supplier: AJANTA PHARMA #1 Buyer: UNILAB INC

MSN Laboratories Private Limited — Febuxostat Exporter #2 | $6.0M Trade Value | TransData Nexus | TransData Nexus

MSN Laboratories Private Limited — Febuxostat Exporter Profile

Indian Pharmaceutical Exporter · #2 for Febuxostat · $6.0M export value · DGFT Verified

MSN Laboratories Private Limited is the #2 Indian exporter of Febuxostat with $6.0M in export value and 342 verified shipments. MSN Laboratories Private Limited holds a 12.3% market share in Febuxostat exports across 27 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.

MSN Laboratories Private Limited — Febuxostat Export Profile: Buyers & Destinations

MSN Laboratories Private Limited Febuxostat export treemap — buyers and destination countries | TransData Nexus

Where Does MSN Laboratories Private Limited Export Febuxostat?

Country	Value	Shipments	Share
UNITED STATES	$2.0M	48	46.2%
MAURITIUS	$479.2K	29	11.0%
UNITED KINGDOM	$280.5K	29	6.5%
COLOMBIA	$177.7K	25	4.1%

Who Are the Top Buyers of Febuxostat from MSN Laboratories Private Limited?

Buyer	Country	Value	Orders
TO THE ORDER OF	UNITED STATES	$2.4M	135
NOVADOZ PHARMACEUTICALS LLC	UNITED STATES	$298.8K	9
SCOTT HEALTH LTD	MAURITIUS	$204.6K	8
TO THE ORDER OF.,	ZAMBIA	$160.8K	14
SCOTT HEALTH LIMITED	MAURITIUS	$101.2K	10
MSN LABS AMERICAS SAS	COLOMBIA	$98.5K	13
SCOTT HEALTH LTD POBOX	MAURITIUS	$85.2K	6
MSN LABORATORIES EUROPE LIMITED	UNITED KINGDOM	$75.7K	6
BENTA SAL	LEBANON	$67.7K	2
MSN LABORATORIES EUROPE LIMITED.,	UNITED KINGDOM	$61.6K	4

MSN Laboratories Private Limited supplies Febuxostat to 52 buyers globally. The largest buyer is TO THE ORDER OF (UNITED STATES), followed by NOVADOZ PHARMACEUTICALS LLC (UNITED STATES) and SCOTT HEALTH LTD (MAURITIUS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Febuxostat Formulations Does MSN Laboratories Private Limited Export?

Product Description / Formulation	Value	Shipments
MSN PHARMA FEBUXOSTAT TABLETS 40 MG	$787.2K	17
MSN PHARMA FEBUXOSTAT TABLETS 80 MG	$643.7K	14
FEBUXOSTAT TABLETS 40 MG	$150.0K	3
FEBUDAY 40 (FEBUXOSTAT 40MG) 3X10	$140.0K	26
FEBUXOSTAT TABLETS 40MG NDC	$128.4K	5
MSN PHARMA FEBUXOSTAT TABLETS 80MG	$100.0K	2
FEBUXOSTAT TABS 80 MG X 28'S MSN UK	$82.9K	6
FEBUXOSTAT TABLETS 80MG X 84 VIVANTA DE	$63.2K	18
MSN LABS, FEBUDAY 40 (FEBUXOSTAT 40MG) 3	$62.0K	4
STATURIC 80 (FEBUXOSTAT 80MG) 3X10	$57.3K	6

MSN Laboratories Private Limited exports 189 distinct Febuxostat formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MSN PHARMA FEBUXOSTAT TABLETS 40 MG with 17 shipments worth $787.2K.

How Does MSN Laboratories Private Limited Compare to Nearest Febuxostat Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	MSN LABORATORIES PRIVATE LIMITED ★	$6.0M	342	27	$17.6K
1	AJANTA PHARMA LIMITED	$4.5M	89	6	$50.0K
3	ALEMBIC PHARMACEUTICALS LIMITED	$2.8M	56	1	$50.0K

MSN Laboratories Private Limited ranks #2 among 182 Indian Febuxostat exporters. Average shipment value of $17.6K compared to the market average of $132.8K. The closest competitors by value are AJANTA PHARMA LIMITED and ALEMBIC PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Febuxostat Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	639	18.3%
SAHAR AIR	615	17.6%
DELHI AIR	387	11.1%
SAHAR AIR CARGO ACC (INBOM4)	351	10.0%
NHAVA SHEVA SEA (INNSA1)	145	4.1%
HYDERABAD ICD (INSNF6)	98	2.8%
HYDERABAD AIR	96	2.7%
Bombay Air	84	2.4%

Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Febuxostat Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)

Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)

In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.

MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.

MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Febuxostat shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: MSN Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 342 individual customs records matching MSN Laboratories Private Limited exporting Febuxostat, covering 189 formulations to 29 countries via 52 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 91+ countries, 421+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Febuxostat

Febuxostat

MSN Laboratories Private Limited — Febuxostat Exporter Profile

MSN Laboratories Private Limited — Febuxostat Export Profile: Buyers & Destinations

Where Does MSN Laboratories Private Limited Export Febuxostat?

Who Are the Top Buyers of Febuxostat from MSN Laboratories Private Limited?

What Is India's Total Febuxostat Export Value and How Much Does MSN Laboratories Private Limited Contribute?

What Is the Average Shipment Value for MSN Laboratories Private Limited's Febuxostat Exports?

How Does MSN Laboratories Private Limited Compare to Other Indian Febuxostat Exporters?

What Febuxostat Formulations Does MSN Laboratories Private Limited Export?

Regulatory Requirements: Exporting Febuxostat to Key Markets

United States — FDA

United Kingdom — MHRA

How Does MSN Laboratories Private Limited Compare to Nearest Febuxostat Exporters?

Which Indian Ports Ship Febuxostat Exports?

Febuxostat — Export Intelligence Video

Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Febuxostat Exports

MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards

About MSN Laboratories Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Febuxostat Export Data from MSN Laboratories Private Limited

Febuxostat Stats

Company Overview

Top Products by MSN Laboratories Private Limited

Related Analysis

Need Detailed Export Data?

Data Source